A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers, families and children has received $22 million from the U.S. Centers for Disease Control and Prevention to continue the research for another year.

COVID vaccine makers are developing new boosters for a fall campaign. But some experts question the FDA's decision to tell companies to make shots against the BA.4/5 subvariants.

Katrina Zearley, a student in the R. Ken Coit College of Pharmacy, discusses why she wrote a children’s book about pharmacy.

CDC funding will allow research on COVID-19 immunity and vaccine effectiveness to continue as new variants emerge.

The new BA-5 variant of the coronavirus is now the dominant strain in Arizona, where it is responsible for slightly less than 60% of new cases.

Margie Balfour, MD, PhD, associate professor of psychiatry in the College of Medicine – Tucson, co-authors a story on the upcoming “soft launch” of a new emergency number for behavioral health emergencies.

A commonly prescribed cancer and arthritis drug sometimes used as an oral abortifacient is facing prescription roadblocks in wake of the Supreme Court's overturning of Roe v Wade.

Esther M. Sternberg, MD, professor of medicine in the College of Medicine – Tucson, will be featured on the July 20 edition of Medical Matters Weekly, produced by Southwestern Vermont Health Care.